Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cyclacel Pharmaceuticals, Inc. (CYCC) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cyclacel Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1130166.
Total stock buying since 2017: $2,331,399.
Total stock sales since 2017: $5,533,078.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 194,635,570 | $5,533,036 | 194,628,820 | $0 |
| 2023 | 7,956 | $26,374 | 0 | $0 | 0 | $0 |
| 2021 | 5,000 | $23,000 | 12 | $42 | 0 | $0 |
| 2017 | 984,200 | $2,282,025 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 6,750 | $83,430 | 0 | $0 |
| 2025-02 | 0 | $0 | 194,628,820 | $5,449,606 | 194,628,820 | $0 |
| 2023-12 | 7,956 | $26,374 | 0 | $0 | 0 | $0 |
| 2021-11 | 4,000 | $18,000 | 12 | $42 | 0 | $0 |
| 2021-08 | 1,000 | $5,000 | 0 | $0 | 0 | $0 |
| 2017-07 | 850,000 | $1,700,000 | 0 | $0 | 0 | $0 |
| 2017-02 | 134,200 | $582,025 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-30 | Lazar David E. | Sale | 6,750 | 12.36 | 83,430 |
| 2025-02-26 | Lazar David E. (Interim CEO) | Sale | 194,628,820 | .03 | 5,449,606 |
| 2025-02-26 | Lazar David E. (Interim CEO) | Option Ex | 194,628,820 | .00 | 0 |
| 2023-12-21 | Mcbarron Paul (See Remarks) | Buy | 1,886 | 3.31 | 6,252 |
| 2023-12-21 | Rombotis Spiro George (President and CEO) | Buy | 6,070 | 3.31 | 20,122 |
| 2021-11-30 | Barker Sam L | Sale | 12 | 3.57 | 42 |
| 2021-11-18 | Rombotis Spiro George (President and CEO) | Buy | 4,000 | 4.50 | 18,000 |
| 2021-08-24 | Barker Sam L | Buy | 1,000 | 5.00 | 5,000 |
| 2017-07-19 | Dart Kenneth Bryan | Buy | 850,000 | 2.00 | 1,700,000 |
| 2017-02-23 | Tang Capital Partners Lp (10% Owner) | Buy | 134,200 | 4.34 | 582,025 |
Insider trading activities including stock purchases, stock sales, and option exercises of CYCC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cyclacel Pharmaceuticals, Inc. (symbol CYCC, CIK number 1130166) see the Securities and Exchange Commission (SEC) website.